Division of Freedom of Information; Change of Office Name, and Removal of Address, Telephone Number, and Fax Number; Technical Amendment, 68114-68116 [2014-26914]
Download as PDF
<![CDATA[
68114
Federal Register / Vol. 79, No. 220 / Friday, November 14, 2014 / Rules and Regulations
Administrative practice and
procedure, News media.
21 CFR Part 14
Food and Drug Administration
21 CFR Parts 5, 10, 14, 20, 21, 314, 350,
516, and 814
[Docket No. FDA–2011–N–0318]
Division of Freedom of Information;
Change of Office Name, and Removal
of Address, Telephone Number, and
Fax Number; Technical Amendment
AGENCY:
Authority: 5 U.S.C. 551–558, 701–706; 15
U.S.C. 1451–1461; 21 U.S.C. 141–149, 321–
397, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42
U.S.C. 201, 262, 263b, 264.
§ 10.85
Administrative practice and
procedure, Advisory committees, Color
additives, Drugs, Radiation protection.
■
21 CFR Part 10
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration,
21 CFR Part 20
Confidential business information,
Courts, Freedom of Information,
Government employees.
Privacy.
Final rule; technical
amendments.
ACTION:
21 CFR Part 314
The Food and Drug
Administration (FDA) is amending the
Agency’s regulations to change the
Division of Freedom of Information’s
(FOI’s) name, and remove the address,
telephone number, fax number, and
Public Reading Room fax number and
room number and replace them with
FOI’s address located on the Agency’s
Web site. This action is editorial in
nature and is intended to improve the
accuracy of the Agency’s regulations.
DATES: This rule is effective November
14, 2014.
FOR FURTHER INFORMATION CONTACT:
Sarah Kotler, Freedom of Information
Staff, Food and Drug Administration,
301–796–8975, address available on the
Agency’s Web site at https://
www.fda.gov.
SUMMARY:
FDA is
making technical amendments in the
Agency’s regulations under 21 CFR
parts 5, 10, 14, 20, 21, 314, 350, 516,
and 814 as a result of a recent office
move. The office name and address was
‘‘Division of Freedom of Information
(ELEM–1029), 12420 Parklawn Dr.,
Element Bldg., Rockville, MD 20857’’.
The new office name and address is
listed on the Agency’s Web site at
https://www.fda.gov. The Freedom of
Information Staff’s new Public Reading
Room number is listed on the Agency’s
Web site at https://www.fda.gov.
Publication of this document constitutes
final action of these changes under the
Administrative Procedures Act (5 U.S.C.
553). FDA has determined that notice
and public comment are unnecessary
because these amendments are merely
correcting nonsubstantive errors.
mstockstill on DSK4VPTVN1PROD with RULES
SUPPLEMENTARY INFORMATION:
List of Subjects
Administrative practice and
procedure, Confidential business
information, Drugs, Reporting and
recordkeeping requirements.
21 CFR Part 350
Labeling, Over-the-counter drugs.
21 CFR Part 516
Administrative practice and
procedure, Animal drugs, Confidential
business information, Reporting and
recordkeeping requirements.
21 CFR Part 814
PART 5—ORGANIZATION
1. The authority citation for 21 CFR
part 5 continues to read as follows:
Authority: 5 U.S.C. 552; 21 U.S.C. 301–
397.
2. In § 5.1110, revise paragraph (b) to
read as follows:
■
§ 5.1110
FDA public information offices.
*
*
*
*
*
(b) Freedom of Information Staff. The
Freedom of Information Staff’s Public
Reading Room is located at the address
available on the Agency’s Web site at
https://www.fda.gov.
*
*
*
*
*
Authority delegations (Government
agencies), Imports, Organization and
functions (Government agencies).
■
Jkt 235001
§ 10.95
[Amended]
6. Section 10.95 is amended in
paragraphs (b)(2), (c)(2), (d)(2), (d)(7),
and (d)(8) by removing ‘‘(ELEM–1029)’’
and adding in its place ‘‘(the Freedom
of Information Staff’s address is
available on the Agency’s Web site at
https://www.fda.gov)’’.
■
PART 14—PUBLIC HEARING BEFORE
A PUBLIC ADVISORY COMMITTEE
7. The authority citation for 21 CFR
part 14 continues to read as follows:
Authority: 5 U.S.C. App. 2; 15 U.S.C.
1451–1461, 21 U.S.C. 41–50, 141–149, 321–
394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42
U.S.C. 201, 262, 263b, 264; Pub. L. 107–109;
Pub. L. 108–155, Pub. L. 113–54.
§ 14.65
[Amended]
8. Section 14.65 is amended in
paragraph (c) by removing ‘‘(ELEM–
1029)’’ and by adding in its place ‘‘(the
Freedom of Information Staff’s address
is available on the Agency’s Web site at
https://www.fda.gov)’’.
■
■
PART 10—ADMINISTRATIVE
PRACTICES AND PROCEDURES
16:41 Nov 13, 2014
[Amended]
5. Section 10.90 is amended in
paragraph (d) by removing ‘‘(ELEM–
1029)’’ and adding in its place ‘‘(the
Freedom of Information Staff’s address
is available on the Agency’s Web site at
https://www.fda.gov)’’.
■
Administrative practice and
procedure, Confidential business
information, Medical devices, Medical
research, Reporting and recordkeeping
requirements.
Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs, 21 CFR parts 5, 10,
14, 20, 21, 314, 350, 516, and 814 are
amended as follows:
21 CFR Part 5
VerDate Sep<11>2014
§ 10.90
■
21 CFR Part 21
HHS.
[Amended]
4. Section 10.85 is amended in
paragraph (d)(4) by removing ‘‘(ELEM–
1029)’’ and adding in its place ‘‘(the
Freedom of Information Staff’s address
is available on the Agency’s Web site at
https://www.fda.gov)’’.
3. The authority citation for 21 CFR
part 10 continues to read as follows:
PO 00000
Frm 00022
Fmt 4700
Sfmt 4700
PART 20—PUBLIC INFORMATION
9. The authority citation for 21 CFR
part 20 continues to read as follows:
■
Authority: 5 U.S.C. 552; 18 U.S.C. 1905; 19
U.S.C. 2531–2582; 21 U.S.C. 321–393, 1401–
1403; 42 U.S.C. 241, 242, 242a, 242l, 242n,
243, 262, 263, 263b–263n, 264, 265, 300u–
300u–5, 300aa–1.
§ 20.3
[Amended]
10. Section 20.3 is amended in
paragraph (b) by removing ‘‘(ELEM–
1029), Food and Drug Administration,
12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857’’ and adding in its
place ’’ at the address located on the
Agency’s Web site at https://
www.fda.gov.’’
■ 11. In § 20.26, revise paragraph (b) to
read as follows:
■
E:\FR\FM\14NOR1.SGM
14NOR1
Federal Register / Vol. 79, No. 220 / Friday, November 14, 2014 / Rules and Regulations
§ 20.26
Indexes of certain records.
*
*
*
*
*
(b) Each such index will be made
available by accessing the Agency’s Web
site at https://www.fda.gov. A printed
copy of each index is available by
writing or visiting the Freedom of
Information Staff’s address on the
Agency’s Web site at https://
www.fda.gov.
§ 20.30
Filing a request for records.
(a) All requests for Food and Drug
Administration records shall be made in
writing by mailing or delivering the
request to the Freedom of Information
Staff at the address on the Agency’s Web
site at https://www.fda.gov or by faxing it
to the fax number listed on the Agency’s
Web site at https://www.fda.gov. All
requests must contain the postal address
and telephone number of the requester
and the name of the person responsible
for payment of any fees that may be
charged.
*
*
*
*
*
§ 20.107
14. Section 20.107 is amended in
paragraph (a) by removing ‘‘(ELEM–
1029), Food and Drug Administration,
12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857’’ and adding in its
place ‘‘at the address located on the
Agency’s Web site at https://
www.fda.gov.’’
■ 15. In § 20.120, revise paragraph (a) to
read as follows:
■
mstockstill on DSK4VPTVN1PROD with RULES
§ 20.120 Records available in Food and
Drug Administration Public Reading
Rooms.
§ 314.53
16. The authority citation for 21 CFR
part 21 continues to read as follows:
■
Authority: 21 U.S.C. 371; 5 U.S.C. 552,
552a.
[Amended]
17. Section 21.32 is amended in
paragraph (b)(2) in the second sentence
by removing ‘‘(HFA–400), Food and
Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857’’ and by
adding in its place ‘‘HR–BETHPL
RM7114, HFA–705, 7700 Wisconsin
Ave., 7th & 8th floors, Bethesda, MD
20814’’ and in the third sentence by
removing ‘‘(ELEM–1029)’’ and by
adding in its place ‘‘(the Privacy Act
Coordinator is part of the Freedom of
Information Staff, the address for which
is located on the Agency Web site at
https://www.fda.gov)’’.
Jkt 235001
23. In § 314.53, in paragraph (e),
revise the last sentence to read as
follows:
Submission of patent information.
*
*
*
*
*
(e) * * * A request for copies of the
file shall be sent in writing to the
Freedom of Information Staff at the
address listed on the Agency’s Web site
at https://www.fda.gov.
*
*
*
*
*
■
§ 21.40
[Amended]
18. Section 21.40 is amended in
paragraph (b) by removing ‘‘(ELEM–
1029), Food and Drug Administration,
12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857’’ and by adding in
its place ‘‘(address is located on the
Agency Web site at https://
www.gov.fda)’’.
■
§ 21.41
[Amended]
19. Section 21.41 is amended in
paragraphs (c) and (e) by removing
‘‘(ELEM–1029)’’ and by adding in its
place ‘‘(address is located on the Agency
Web site at https://www.gov.fda)’’.
§ 21.43
[Amended]
20. Section 21.43 is amended in
paragraph (a)(2) by removing ‘‘at the
address shown in § 20.30 of this
chapter’’ and by adding in its place
‘‘(address is located on the Agency’s
Web site at https://www.fda.gov)’’.
■
§ 21.52
(a) The Freedom of Information Staff
and the Division of Dockets
Management Public Reading Room are
located at the same address. Both are
located in rm. 1061, 5630 Fishers Lane,
Rockville, MD 20852. The telephone
number for the Division of Docket
Management is 301–827–6860; the
telephone number for the Freedom of
Information Staff’s Public Reading
Room is located at the address on the
Agency’s Web site at https://
www.fda.gov. Both public reading rooms
are open from 9 a.m. to 4 p.m., Monday
16:41 Nov 13, 2014
PART 21—PROTECTION OF PRIVACY
■
[Amended]
VerDate Sep<11>2014
■
§ 21.32
[Amended]
12. Section 20.30 is amended in
paragraph (a) by removing ‘‘(ELEM–
1029), Food and Drug Administration,
12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857’’ and adding in its
place ‘‘at the address located on the
Agency’s Web site at https://
www.fda.gov.’’
■ 13. In § 20.40, revise paragraph (a) to
read as follows:
■
§ 20.40
through Friday, excluding legal public
holidays.
*
*
*
*
*
68115
[Amended]
21. Section 21.52 is amended in
paragraph (a) by removing ‘‘, Rm. 14–71,
5600 Fishers Lane, Rockville, MD
20857’’ and by adding in its place ‘‘(see
the address on the Agency’s Web site at
https://www.fda.gov)’’.
■
PART 314—APPLICATIONS FOR FDA
APPROVAL TO MARKET A NEW DRUG
22. The authority citation for 21 CFR
part 314 continues to read as follows:
■
Authority: 21 U.S.C. 321, 331, 351, 352,
353, 355, 356, 356a, 356b, 356c, 371, 374,
379e.
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
PART 350—ANTIPERSPIRANT DRUG
PRODUCTS FOR OVER-THECOUNTER HUMAN USE
24. The authority citation for 21 CFR
part 350 continues to read as follows:
■
Authority: 21 U.S.C. 321, 351, 352, 353,
355, 360, 371.
§ 350.60
[Amended]
25. Section 350.60 is amended by
removing ‘‘(ELEM–1029), Food and
Drug Administration, 12420 Parklawn
Dr., Element Bldg., Rockville, MD
20857’’ and adding in its place
‘‘(address is located on the Agency’s
Web site at
https://www.fda.gov.’’
■
PART 516—NEW ANIMAL DRUGS FOR
MINOR USE AND MINOR SPECIES
26. The authority citation for part 516
continues to read as follows:
■
Authority: 21 U.S.C. 360ccc–1, 360ccc–2,
371.
27. In § 516.157, revise paragraph (a)
to read as follows:
■
§ 516.157 Publication of the index and
content of an index listing.
(a) FDA will make the list of indexed
drugs available through the FDA Web
site at https://www.fda.gov. A printed
copy can be obtained by writing to the
Freedom of Information Staff or by
visiting FDA’s Freedom of Information
Staff’s Public Reading Room at the
address listed on the Agency’s Web site
at https://www.fda.gov.
*
*
*
*
*
PART 814—PREMARKET APPROVAL
OF MEDICAL DEVICES
28. The authority citation for 21 CFR
part 814 continues to read as follows:
■
Authority: 21 U.S.C. 351, 352, 353, 360,
360c–360j, 371, 372, 373, 374, 375, 379, 379e,
381.
29. In § 814.45, revise paragraph (d)(2)
to read as follows:
■
§ 814.45
*
Denial of approval of a PMA.
*
*
(d) * * *
E:\FR\FM\14NOR1.SGM
14NOR1
*
*
68116
Federal Register / Vol. 79, No. 220 / Friday, November 14, 2014 / Rules and Regulations
(2) A request for copies of the current
PMA approvals and denials document
and copies of summaries of safety and
effectiveness shall be sent in writing to
the Freedom of Information Staff’s
address listed on the Agency’s Web site
at https://www.fda.gov.
*
*
*
*
*
Dated: November 7, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–26914 Filed 11–13–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF STATE
22 CFR Part 181
[Public Notice 8921]
RIN 1400–AD53
Publication, Coordination, and
Reporting of International Agreements
ACTION:
Final rule.
The Department of State
(‘‘Department’’) finalizes a proposed
rule to add additional categories of
international agreements to be exempted
from the requirement to publish in the
Treaties and Other International Acts
Series (TIAS). The TIAS is the official
treaty series of the United States and
serves as evidence of the treaties, and
international agreements other than
treaties, in all courts of law and equity
and of maritime jurisdiction, and in all
the tribunals and public offices of the
United States and of the several States,
without any need of further proof or
authentication. Certain international
agreements may be exempted from
publication in TIAS if the Department of
State provides notice in its regulations.
This rule adds three categories of
international agreements that are not
required to be published in TIAS.
DATES: This rule is effective on
November 14, 2014.
FOR FURTHER INFORMATION CONTACT:
Michael Mattler, Treaty Affairs, Office
of the Legal Adviser, Department of
State, Washington, DC 20520, (202)
647–1345, or at treatyoffice@state.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to 1 U.S.C. 112a, the Secretary of State
is required to cause to be published
annually a compilation of all treaties
and international agreements to which
the United States is a party that were
signed, proclaimed, or ‘‘with reference
to which any other final formality ha[d]
been executed’’ during the calendar
year.
The Secretary of State, however, may
determine that publication of particular
mstockstill on DSK4VPTVN1PROD with RULES
SUMMARY:
VerDate Sep<11>2014
16:41 Nov 13, 2014
Jkt 235001
categories of agreements is not required
if certain criteria are met, which are
listed in 1 U.S.C. 112a(b). The three
categories of international agreements
that are exempted by this rule (and
which are now included in 22 CFR
181.8) are:
(1) Bilateral acquisition and cross
servicing agreements and logistics
support agreements governing the
mutual exchange of logistics support,
supplies and services with the military
of certain countries or international
organizations.
(2) Bilateral agreements relating to the
provision of health care to military
personnel on a reciprocal basis.
(3) Bilateral agreements for the
reduction of intergovernmental debts.
Further description of these types of
international agreements is included in
the notice of proposed rulemaking. In
addition to these changes, the
Department amends 22 CFR 181.8(a)(9)
to refer to the newer Executive Order
dealing with classified information.
The Department of State received no
comments on the proposed rule.
Regulatory Analysis
For the complete regulatory analysis
regarding this rulemaking, please refer
to the analysis included in the notice of
proposed rulemaking, which is adopted
herein.
List of Subjects in 22 CFR Part 181
Treaties.
For the reasons set forth above, 22
CFR part 181 is amended as follows:
specialized aspects of each other’s
practices or operations;
(13) Bilateral agreements between
aviation agencies governing specified
aviation technical assistance projects for
the provision of managerial, operational,
and technical assistance in developing
and modernizing the civil aviation
infrastructure;
(14) Bilateral acquisition and cross
servicing agreements and logistics
support agreements;
(15) Bilateral agreements relating to
the provision of health care to military
personnel on a reciprocal basis; and
(16) Bilateral agreements for the
reduction of intergovernmental debts.
(b) In addition to those listed in
paragraph (a) of this section, the
following categories of agreements will
not be published in United States
Treaties and Other International
Agreements:
(1) Agreements on the subjects listed
in paragraphs (a)(1) through (9) of this
section that had not been published as
of February 26, 1996;
(2) Agreements on the subjects listed
in paragraphs (a)(10) through (13) of this
section that had not been published as
of September 8, 2006; and
(3) Agreements on the subjects listed
in paragraphs (a)(14) through (16) of this
section that had not been published as
of November 14, 2014.
*
*
*
*
*
Dated: November 5, 2014.
Michael J. Mattler,
Assistant Legal Adviser for Treaty Affairs,
Department of State.
[FR Doc. 2014–27006 Filed 11–13–14; 8:45 am]
PART 181—[AMENDED]
BILLING CODE 4710–08–P
1. The authority citation for part 181
continues to read as follows:
■
Authority: 1 U.S.C. 112a, 112b; and 22
U.S.C. 2651a.
2. Amend § 181.8 by:
a. Revising paragraphs (a)(9), (12), and
(13) and adding paragraphs (a)(14), (15),
and (16); and
■ b. Revising paragraph (b).
The revisions and additions read as
follows:
■
■
§ 181.8
Publication.
(a) * * *
(9) Agreements that have been given
a national security classification
pursuant to Executive Order No. 13526,
its predecessors, or its successors;
*
*
*
*
*
(12) Bilateral agreements that apply to
specified education and leadership
development programs designed to
acquaint U.S. and foreign armed forces,
law enforcement, homeland security, or
related personnel with limited,
PO 00000
Frm 00024
Fmt 4700
Sfmt 4700
PENSION BENEFIT GUARANTY
CORPORATION
29 CFR Part 4022
Benefits Payable in Terminated SingleEmployer Plans; Interest Assumptions
for Paying Benefits
Pension Benefit Guaranty
Corporation.
ACTION: Final rule.
AGENCY:
This final rule amends the
Pension Benefit Guaranty Corporation’s
regulation on Benefits Payable in
Terminated Single-Employer Plans to
prescribe interest assumptions under
the regulation for valuation dates in
December 2014. The interest
assumptions are used for paying
benefits under terminating singleemployer plans covered by the pension
insurance system administered by
PBGC.
SUMMARY:
E:\FR\FM\14NOR1.SGM
14NOR1
]]>Agencies
[Federal Register Volume 79, Number 220 (Friday, November 14, 2014)]
[Rules and Regulations]
[Pages 68114-68116]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26914]
[[Page 68114]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 5, 10, 14, 20, 21, 314, 350, 516, and 814
[Docket No. FDA-2011-N-0318]
Division of Freedom of Information; Change of Office Name, and
Removal of Address, Telephone Number, and Fax Number; Technical
Amendment
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; technical amendments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the
Agency's regulations to change the Division of Freedom of Information's
(FOI's) name, and remove the address, telephone number, fax number, and
Public Reading Room fax number and room number and replace them with
FOI's address located on the Agency's Web site. This action is
editorial in nature and is intended to improve the accuracy of the
Agency's regulations.
DATES: This rule is effective November 14, 2014.
FOR FURTHER INFORMATION CONTACT: Sarah Kotler, Freedom of Information
Staff, Food and Drug Administration, 301-796-8975, address available on
the Agency's Web site at https://www.fda.gov.
SUPPLEMENTARY INFORMATION: FDA is making technical amendments in the
Agency's regulations under 21 CFR parts 5, 10, 14, 20, 21, 314, 350,
516, and 814 as a result of a recent office move. The office name and
address was ``Division of Freedom of Information (ELEM-1029), 12420
Parklawn Dr., Element Bldg., Rockville, MD 20857''. The new office name
and address is listed on the Agency's Web site at https://www.fda.gov.
The Freedom of Information Staff's new Public Reading Room number is
listed on the Agency's Web site at https://www.fda.gov. Publication of
this document constitutes final action of these changes under the
Administrative Procedures Act (5 U.S.C. 553). FDA has determined that
notice and public comment are unnecessary because these amendments are
merely correcting nonsubstantive errors.
List of Subjects
21 CFR Part 5
Authority delegations (Government agencies), Imports, Organization
and functions (Government agencies).
21 CFR Part 10
Administrative practice and procedure, News media.
21 CFR Part 14
Administrative practice and procedure, Advisory committees, Color
additives, Drugs, Radiation protection.
21 CFR Part 20
Confidential business information, Courts, Freedom of Information,
Government employees.
21 CFR Part 21
Privacy.
21 CFR Part 314
Administrative practice and procedure, Confidential business
information, Drugs, Reporting and recordkeeping requirements.
21 CFR Part 350
Labeling, Over-the-counter drugs.
21 CFR Part 516
Administrative practice and procedure, Animal drugs, Confidential
business information, Reporting and recordkeeping requirements.
21 CFR Part 814
Administrative practice and procedure, Confidential business
information, Medical devices, Medical research, Reporting and
recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, 21 CFR parts
5, 10, 14, 20, 21, 314, 350, 516, and 814 are amended as follows:
PART 5--ORGANIZATION
0
1. The authority citation for 21 CFR part 5 continues to read as
follows:
Authority: 5 U.S.C. 552; 21 U.S.C. 301-397.
0
2. In Sec. 5.1110, revise paragraph (b) to read as follows:
Sec. 5.1110 FDA public information offices.
* * * * *
(b) Freedom of Information Staff. The Freedom of Information
Staff's Public Reading Room is located at the address available on the
Agency's Web site at https://www.fda.gov.
* * * * *
PART 10--ADMINISTRATIVE PRACTICES AND PROCEDURES
0
3. The authority citation for 21 CFR part 10 continues to read as
follows:
Authority: 5 U.S.C. 551-558, 701-706; 15 U.S.C. 1451-1461; 21
U.S.C. 141-149, 321-397, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42
U.S.C. 201, 262, 263b, 264.
Sec. 10.85 [Amended]
0
4. Section 10.85 is amended in paragraph (d)(4) by removing ``(ELEM-
1029)'' and adding in its place ``(the Freedom of Information Staff's
address is available on the Agency's Web site at https://www.fda.gov)''.
Sec. 10.90 [Amended]
0
5. Section 10.90 is amended in paragraph (d) by removing ``(ELEM-
1029)'' and adding in its place ``(the Freedom of Information Staff's
address is available on the Agency's Web site at https://www.fda.gov)''.
Sec. 10.95 [Amended]
0
6. Section 10.95 is amended in paragraphs (b)(2), (c)(2), (d)(2),
(d)(7), and (d)(8) by removing ``(ELEM-1029)'' and adding in its place
``(the Freedom of Information Staff's address is available on the
Agency's Web site at https://www.fda.gov)''.
PART 14--PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
0
7. The authority citation for 21 CFR part 14 continues to read as
follows:
Authority: 5 U.S.C. App. 2; 15 U.S.C. 1451-1461, 21 U.S.C. 41-
50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42
U.S.C. 201, 262, 263b, 264; Pub. L. 107-109; Pub. L. 108-155, Pub.
L. 113-54.
Sec. 14.65 [Amended]
0
8. Section 14.65 is amended in paragraph (c) by removing ``(ELEM-
1029)'' and by adding in its place ``(the Freedom of Information
Staff's address is available on the Agency's Web site at https://www.fda.gov)''.
PART 20--PUBLIC INFORMATION
0
9. The authority citation for 21 CFR part 20 continues to read as
follows:
Authority: 5 U.S.C. 552; 18 U.S.C. 1905; 19 U.S.C. 2531-2582; 21
U.S.C. 321-393, 1401-1403; 42 U.S.C. 241, 242, 242a, 242l, 242n,
243, 262, 263, 263b-263n, 264, 265, 300u-300u-5, 300aa-1.
Sec. 20.3 [Amended]
0
10. Section 20.3 is amended in paragraph (b) by removing ``(ELEM-1029),
Food and Drug Administration, 12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857'' and adding in its place '' at the address located
on the Agency's Web site at https://www.fda.gov.''
0
11. In Sec. 20.26, revise paragraph (b) to read as follows:
[[Page 68115]]
Sec. 20.26 Indexes of certain records.
* * * * *
(b) Each such index will be made available by accessing the
Agency's Web site at https://www.fda.gov. A printed copy of each index
is available by writing or visiting the Freedom of Information Staff's
address on the Agency's Web site at https://www.fda.gov.
Sec. 20.30 [Amended]
0
12. Section 20.30 is amended in paragraph (a) by removing ``(ELEM-
1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857'' and adding in its place ``at the address located
on the Agency's Web site at https://www.fda.gov.''
0
13. In Sec. 20.40, revise paragraph (a) to read as follows:
Sec. 20.40 Filing a request for records.
(a) All requests for Food and Drug Administration records shall be
made in writing by mailing or delivering the request to the Freedom of
Information Staff at the address on the Agency's Web site at https://www.fda.gov or by faxing it to the fax number listed on the Agency's
Web site at https://www.fda.gov. All requests must contain the postal
address and telephone number of the requester and the name of the
person responsible for payment of any fees that may be charged.
* * * * *
Sec. 20.107 [Amended]
0
14. Section 20.107 is amended in paragraph (a) by removing ``(ELEM-
1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857'' and adding in its place ``at the address located
on the Agency's Web site at https://www.fda.gov.''
0
15. In Sec. 20.120, revise paragraph (a) to read as follows:
Sec. 20.120 Records available in Food and Drug Administration Public
Reading Rooms.
(a) The Freedom of Information Staff and the Division of Dockets
Management Public Reading Room are located at the same address. Both
are located in rm. 1061, 5630 Fishers Lane, Rockville, MD 20852. The
telephone number for the Division of Docket Management is 301-827-6860;
the telephone number for the Freedom of Information Staff's Public
Reading Room is located at the address on the Agency's Web site at
https://www.fda.gov. Both public reading rooms are open from 9 a.m. to 4
p.m., Monday through Friday, excluding legal public holidays.
* * * * *
PART 21--PROTECTION OF PRIVACY
0
16. The authority citation for 21 CFR part 21 continues to read as
follows:
Authority: 21 U.S.C. 371; 5 U.S.C. 552, 552a.
Sec. 21.32 [Amended]
0
17. Section 21.32 is amended in paragraph (b)(2) in the second sentence
by removing ``(HFA-400), Food and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857'' and by adding in its place ``HR-BETHPL
RM7114, HFA-705, 7700 Wisconsin Ave., 7th & 8th floors, Bethesda, MD
20814'' and in the third sentence by removing ``(ELEM-1029)'' and by
adding in its place ``(the Privacy Act Coordinator is part of the
Freedom of Information Staff, the address for which is located on the
Agency Web site at https://www.fda.gov)''.
Sec. 21.40 [Amended]
0
18. Section 21.40 is amended in paragraph (b) by removing ``(ELEM-
1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857'' and by adding in its place ``(address is located
on the Agency Web site at https://www.gov.fda)''.
Sec. 21.41 [Amended]
0
19. Section 21.41 is amended in paragraphs (c) and (e) by removing
``(ELEM-1029)'' and by adding in its place ``(address is located on the
Agency Web site at https://www.gov.fda)''.
Sec. 21.43 [Amended]
0
20. Section 21.43 is amended in paragraph (a)(2) by removing ``at the
address shown in Sec. 20.30 of this chapter'' and by adding in its
place ``(address is located on the Agency's Web site at https://www.fda.gov)''.
Sec. 21.52 [Amended]
0
21. Section 21.52 is amended in paragraph (a) by removing ``, Rm. 14-
71, 5600 Fishers Lane, Rockville, MD 20857'' and by adding in its place
``(see the address on the Agency's Web site at https://www.fda.gov)''.
PART 314--APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
0
22. The authority citation for 21 CFR part 314 continues to read as
follows:
Authority: 21 U.S.C. 321, 331, 351, 352, 353, 355, 356, 356a,
356b, 356c, 371, 374, 379e.
0
23. In Sec. 314.53, in paragraph (e), revise the last sentence to read
as follows:
Sec. 314.53 Submission of patent information.
* * * * *
(e) * * * A request for copies of the file shall be sent in writing
to the Freedom of Information Staff at the address listed on the
Agency's Web site at https://www.fda.gov.
* * * * *
PART 350--ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN
USE
0
24. The authority citation for 21 CFR part 350 continues to read as
follows:
Authority: 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.
Sec. 350.60 [Amended]
0
25. Section 350.60 is amended by removing ``(ELEM-1029), Food and Drug
Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD
20857'' and adding in its place ``(address is located on the Agency's
Web site at https://www.fda.gov.''
PART 516--NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
0
26. The authority citation for part 516 continues to read as follows:
Authority: 21 U.S.C. 360ccc-1, 360ccc-2, 371.
0
27. In Sec. 516.157, revise paragraph (a) to read as follows:
Sec. 516.157 Publication of the index and content of an index
listing.
(a) FDA will make the list of indexed drugs available through the
FDA Web site at https://www.fda.gov. A printed copy can be obtained by
writing to the Freedom of Information Staff or by visiting FDA's
Freedom of Information Staff's Public Reading Room at the address
listed on the Agency's Web site at https://www.fda.gov.
* * * * *
PART 814--PREMARKET APPROVAL OF MEDICAL DEVICES
0
28. The authority citation for 21 CFR part 814 continues to read as
follows:
Authority: 21 U.S.C. 351, 352, 353, 360, 360c-360j, 371, 372,
373, 374, 375, 379, 379e, 381.
0
29. In Sec. 814.45, revise paragraph (d)(2) to read as follows:
Sec. 814.45 Denial of approval of a PMA.
* * * * *
(d) * * *
[[Page 68116]]
(2) A request for copies of the current PMA approvals and denials
document and copies of summaries of safety and effectiveness shall be
sent in writing to the Freedom of Information Staff's address listed on
the Agency's Web site at https://www.fda.gov.
* * * * *
Dated: November 7, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-26914 Filed 11-13-14; 8:45 am]
BILLING CODE 4164-01-P
